Naborforce vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Idexx Laboratories leads in AI visibility (94 vs 43)
Naborforce logo

Naborforce

EmergingHealthcare

General

Richmond VA YC W20 on-demand senior companion platform with 1,000%+ pandemic revenue growth; $13.5M total ($9M Translink Series A 2022) connecting older adults with vetted Nabors for companionship, errands, and transportation competing with Papa.

AI VisibilityBeta
Overall Score
C43
Category Rank
#1099 of 1158
AI Consensus
74%
Trend
up
Per Platform
ChatGPT
38
Perplexity
41
Gemini
34

About

Naborforce is a Richmond, Virginia-based on-demand senior companionship and assistance platform — backed by Y Combinator (W20) with approximately $13.5 million in total funding including a $9 million Series A in August 2022 led by Translink Capital with Claritas Capital, The Artemis Fund, and TechStars — providing older adults with on-demand access to a vetted network of 'Nabors' (friendly helpers who are not healthcare providers) for social engagement, companionship, errands, transportation, and light assistance around the home. Founded in 2016, Naborforce grew revenue over 1,000% and expanded its client base over 800% during the COVID-19 pandemic, demonstrating the pent-up demand for senior social connection and practical assistance services.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

AI Visibility Head-to-Head

43
Overall Score
94
#1099
Category Rank
#19
74
AI Consensus
71
up
Trend
stable
38
ChatGPT
99
41
Perplexity
92
34
Gemini
88
43
Claude
94
45
Grok
99

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.